Related Experiment Video
Updated: Feb 16, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Understanding childhood diabetes mellitus: new pathophysiological aspects
Juergen Grulich-Henn1, Daniela Klose2
1University Children´s Hospital, University of Heidelberg, Im Neuenheimer Feld 430, Heidelberg, D-69120, Germany. Juergen.Grulich-Henn@med.uni-heidelberg.de.
Diabetes mellitus (DM) encompasses diverse conditions affecting insulin. Research reveals T1DM and T2DM have distinct genetics and metabolic patterns, with specific forms like MODY and CFRDM offering insights into personalized therapies.
Area of Science:
- Endocrinology
- Genetics
- Immunology
Background:
- Diabetes mellitus (DM) is a group of disorders characterized by disturbed insulin synthesis, release, or action.
- Type 1 DM (T1DM) involves autoimmune destruction of islet cells, but is increasingly recognized as heterogeneous with genetic and epigenetic influences.
- Type 2 DM (T2DM) has distinct genetic and metabolic profiles from T1DM, with some overlap in specific populations.
Purpose of the Study:
- To explore the heterogeneity of diabetes mellitus.
- To differentiate the pathogenesis and genetics of various DM types, including T1DM, T2DM, MODY, neonatal DM, and CFRDM.
- To highlight advancements in understanding specific DM subtypes for improved diagnostics and therapeutics.
Main Methods:
- Review and synthesis of current research on DM pathogenesis and genetics.
- Analysis of genetic associations, epigenetic factors, and metabolic patterns across different DM types.
- Examination of molecular mechanisms in specific DM forms like MODY, neonatal DM, and CFRDM.
Main Results:
- T1DM exhibits significant genetic and epigenetic heterogeneity.
- T2DM possesses distinct genetic and metabolic characteristics compared to T1DM.
- Molecular characterization of MODY, neonatal DM, and CFRDM has clarified their pathophysiology, revealing genetic overlaps and specific mechanisms like CFTR dysfunction in CFRDM.
Conclusions:
- DM is a complex, heterogeneous group of diseases rather than a single entity.
- Understanding the distinct genetic and pathophysiological underpinnings of various DM subtypes is crucial for developing precise and individualized treatment strategies.
- Further research into specific DM forms like CFRDM emphasizes their unique disease characteristics and genetic basis.
More Related Videos
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

